Cooperation and innovation: An interview with Minister Ibrokhim Y. Abdurakhmonov and Professor Jinghua Cao
Abstract
4C principles proposed by Prof. George Fu Gao, viz cooperation/collaboration, competition, communication, and coordination, are a stimulus for scientific progress and social development. The basis of scientific research lies in collaboration, with multiple platforms established to support this, from the small scale within labs and individual institutions to the international level. In this dialogue, the recipient of the 2023 VCANBIO Award for International Cooperation Life Sciences and Medicine, Minister Ibrokhim Yulchievich Abdurakhmonov (Minister of Agriculture for Uzbekistan, former Minister of Innovative Development, 2017–2022, and former Minister of Higher Education, Science and Innovation in 2022), discusses both the importance of multilateral communication and collaboration, as well as outlines his vision for furthering Uzbek-Chinese cooperation. Having made many outstanding contributions to the field of modern life and bioscience, Minister Abdurakhmonov has also become a prominent example of the success and close collaboration resulting from the Belt and Road Initiative (BRI). His team helped in line with Chinese scientists pioneering the clinical trails to develop a protein subunit vaccine for COVID-19 that was approved for use in both Uzbekistan and China. Here, he talks with Dr. Qun Yan, head of the hLife Editorial Office, in a joint discussion with Prof. Jinghua Cao, the outgoing Executive Director of the Alliance of National and International Science Organisations (ANSO) for the Belt and Road Regions, who played a crucial role in bridging the vaccine cooperation between China and Uzbekistan.
References
Ayubov MS, Buriev ZT, Mirzakhmedov MK, Yusupov AN, Usmanov DE, Shermatov SE, et al. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan. PLoS One 2022;7:e0266417.
Abdullaev A, Abdurakhimov A, Mirakbarova Z, Ibragimova S, Tsoy V, Nuriddinov S, et al. Genome sequence diversity of SARS-CoV-2, obtained from clinical samples in Uzbekistan. PLoS One 2022;17:e0270314.
Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, et al. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell 2020;182:722-733.e711.
Miller J, Şahin U, Türeci Ö. The vaccines. New York: St. Martin’s Press; 2022.
Dai L, Gao L, Tao L, Hadinegoro SR, Erkin M, Ying Z, et al. Efficacy and safety of the RBD-dimer-based COVID-19 vaccine ZF2001 in adults. N Engl J Med 2022;386:2097-111.
Abdurakhmonov IY. COVID-19 vaccines – current state and perspectives. London: Intech Open; 2023.
Buriev ZT, Shermatov SE, Usmanov DE, Mirzakhmedov MK, Ubaydullaeva KA, Kamburova VS, et al. Tomato-made edible COVID-19 vaccine TOMAVAC induces neutralizing IgGs in the blood sera of mice and humans. Front Nutr 2024;10:1275307.
Garib V, Katsamaki S, Turdikulova S, Levitskaya Y, Zahidova N, Bus G, et al. Milk of cow and goat, immunized by recombinant protein vaccine ZF-UZ-VAC2001 (Zifivax), contains neutralizing antibodies against SARS-CoV-2 and remains active after standard milk pasteurization. Front Nutr 2022;9:901871.
Salikhov SI, Abdurakhmonov IY, Oshchepkova YI, Ziyavitdinov JF, Berdiev NS, Aisa HA, et al. Repurposing of Rutan showed effective treatment for COVID-19 disease. Front Med 2023;10:1310129.
Gao GF, Nkengasong JN. Public health priorities for China–Africa cooperation. Lancet Public Health 2019;4:177-8.
Gao GF, Liu AH. Influenza virus: The inevitable enemy. Singapore: World Scientific; 2024.
Gao GF. Active promotion of bio-industry technology development in China. Chin J Biotechnol 2022;38:4012-8 (in Chinese).
京公网安备11010802044758号